These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2494728)
1. Biological efficacy of a boronated porphyrin as measured in cell culture. Laster BH; Kahl SB; Kalef-Ezra J; Popenoe EA; Fairchild RG Strahlenther Onkol; 1989; 165(2-3):203-5. PubMed ID: 2494728 [No Abstract] [Full Text] [Related]
2. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. Fairchild RG; Kahl SB; Laster BH; Kalef-Ezra J; Popenoe EA Cancer Res; 1990 Aug; 50(16):4860-5. PubMed ID: 2379150 [TBL] [Abstract][Full Text] [Related]
3. Biological efficacy of thermal neutrons using Na2(10)B12H11SH studied in vivo on B-16 mouse melanoma. Spryshkova R; Naidenov M; Borisov G; Komkov M; Bratsev V; Serebryakov N; Demidov A Strahlenther Onkol; 1989; 165(2-3):213-5. PubMed ID: 2494732 [No Abstract] [Full Text] [Related]
4. Boron determination for neutron capture therapy by colorimetry and emission spectrometry. Strouf O; Mertenová E; Schneiderová L; Zámecníková H; Janků I Strahlenther Onkol; 1989; 165(2-3):174-6. PubMed ID: 2494723 [No Abstract] [Full Text] [Related]
5. Enhanced survival in a rat glioma model following BNCT. Clendenon NR; Barth RF; Goodman JH; Staubus AE; Gordon WA; Moeschberger ML; Alam F; Soloway AH; Fairchild RG; Slatkin DN Strahlenther Onkol; 1989; 165(2-3):222-5. PubMed ID: 2494736 [No Abstract] [Full Text] [Related]
6. Canine spontaneous brain tumors--a large animal model for BNCT. Gavin PR; Kraft SL; Wendling LR; Miller DL Strahlenther Onkol; 1989; 165(2-3):225-8. PubMed ID: 2494737 [No Abstract] [Full Text] [Related]
7. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia. Sourek K; Tovarys F Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741 [No Abstract] [Full Text] [Related]
8. Comparative microscopic study on response of Ehrlich carcinoma to BNCT vs. chemo- and radiotherapy. Samarrai SF; al-Mufti AW; Hikmat S; Karim JM; al-Hayani R; Sugano H; Saito T; Tsukagoshi S; Amano K; Hatanaka H Strahlenther Onkol; 1989; 165(2-3):217-8. PubMed ID: 2494734 [No Abstract] [Full Text] [Related]
9. The incorporation of boronated substances into melanin in vitro--an experimental model for melanotic melanoma. Roberto A; Larsson BS Strahlenther Onkol; 1989; 165(2-3):165-7. PubMed ID: 2494722 [No Abstract] [Full Text] [Related]
11. Boronated antibodies for neutron capture therapy. Abraham R; Müller R; Gabel D Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718 [No Abstract] [Full Text] [Related]
12. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia. Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717 [No Abstract] [Full Text] [Related]
13. Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy. Barth RF; Mafune N; Alam F; Adams DM; Soloway AH; Makroglou GE; Oredipe OA; Blue TE; Steplewski Z Strahlenther Onkol; 1989; 165(2-3):142-5. PubMed ID: 2494716 [No Abstract] [Full Text] [Related]
14. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy. Mill AJ Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726 [No Abstract] [Full Text] [Related]
15. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro. Ziegler W; Sauerwein W; Streffer C Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731 [No Abstract] [Full Text] [Related]